Evidence map›Paper›PMID 34368984›Full record

ReviewThe EMBO journal2021

Cell competition in intratumoral and tumor microenvironment interactions.

Taylor M Parker, Kartik Gupta, António M Palma, Michail Yekelchyk, Paul B Fisher, Steven R Grossman, Kyoung Jae Won, Esha Madan, Eduardo Moreno, Rajan Gogna

Open access · hybridAbstract readReview
In one paragraph

Review in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
7.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Cell competition driven by secreted ligands: Modeling liver metastasis of colorectal cancer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Anti-Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte-Driven Responses Rather Than Direct Tumour Cytotoxicity.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Taylor M ParkerDepartment of Biochemistry, West Virginia University School of Medicine, Morgantown, WV, USA.
Kartik GuptaDepartment of Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
António M PalmaChampalimaud Centre for the Unknown, Lisbon, Portugal.
Michail YekelchykDepartment of Cardiac Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-4792-4131
Paul B FisherDepartment of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Steven R GrossmanDepartment of Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Kyoung Jae WonBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen North, Denmark.ORCID 0000-0002-2924-9630
Esha MadanChampalimaud Centre for the Unknown, Lisbon, Portugal.
Eduardo MorenoChampalimaud Centre for the Unknown, Lisbon, Portugal.ORCID 0000-0001-5040-452X
Rajan GognaBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen North, Denmark.ORCID 0000-0001-7304-7692
Champalimaud Foundation · PTUniversity of Copenhagen · DKMax Planck Institute for Heart and Lung Research · DEUniversity of Southern California · USUniversity of Wisconsin–Madison · USVirginia Commonwealth University · USWest Virginia University · US

Funding

Novel Targeted Combinatorial Therapy for Hepatocellular CarcinomaR01CA244993 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FISHER, PAUL B, SARKAR, DEVANAND · 2020 to 2024
$2.7M
Interplay between tumor and microenvironment in bone metastasisR01CA259599 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FISHER, PAUL B, WANG, XIANG-YANG SHAWN · 2021 to 2025
$2.3M
NCI NIH HHS R01 CA244993NCI NIH HHS R01 CA259599
6 · The paper itself

Abstract

Tumors are complex cellular and acellular environments within which cancer clones are under continuous selection pressures. Cancer cells are in a permanent mode of interaction and competition with each other as well as with the immediate microenvironment. In the course of these competitive interactions, cells share information regarding their general state of fitness, with less-fit cells being typically eliminated via apoptosis at the hands of those cells with greater cellular fitness. Competitive interactions involving exchange of cell fitness information have implications for tumor growth, metastasis, and therapy outcomes. Recent research has highlighted sophisticated pathways such as Flower, Hippo, Myc, and p53 signaling, which are employed by cancer cells and the surrounding microenvironment cells to achieve their evolutionary goals by means of cell competition mechanisms. In this review, we discuss these recent findings and explain their importance and role in evolution, growth, and treatment of cancer. We further consider potential physiological conditions, such as hypoxia and chemotherapy, that can function as selective pressures under which cell competition mechanisms may evolve differently or synergistically to confer oncogenic advantages to cancer.

Indexed as

Cell CompetitionTumor MicroenvironmentAnimalsHumansNeoplasmsSignal Transductioncancercell competitionchemotherapyclonal selectiontumor heterogeneity

Identifiers

PMID34368984
PMCPMC8408594
OpenAlexW3190658316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.